Company AusCann Group Holdings Ltd

AC8

AU000000AC89

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 02:10:35 2022-08-31 am EDT			5-day change	1st Jan Change
0.04 ^AUD	-4.76%		-.--%	-.--%

Apr. 03	AusCann Group Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	CI
Jan. 25	AusCann Group Seeks to Raise Up to AU$1 Million Via Share Purchase Plan	MT

AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Its products include Neuvis, CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways. MicroMAX is an encapsulation technology for use in the field of animal therapeutics. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.

Managers	Title	Age	Since
Christopher Mews DFI	Director of Finance/CFO	-	19-11-30

Members of the board	Title	Age	Since
Brett Mitchell BRD	Director/Board Member	53	23-06-28
Christopher Mews DFI	Director of Finance/CFO	-	19-11-30
Andrew Chapman CHM	Chairman	-	Nov. 30
Robert Clifford BRD	Director/Board Member	-	21-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	440,547,110	317,757,177 ( 72.13 %)	0	72.13 %

Name	Equities	%	Valuation
Krista Bates 0.0970 %	427,500	0.0970 %	11 722 $
Evolve Funds Group, Inc. 0.0131 %	57,863	0.0131 %	1 587 $
1st Capital Management Group GmbH 0.000000 %	0	0.000000 %	- $

AusCann Group Holdings Ltd.

16 OConnell Street Level 2

2000, Sydney

+61 8 6305 0705

http://www.auscann.com.au

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
AUSCANN GROUP HOLDINGS LTD	-.--%	11.35M
ELI LILLY AND COMPANY	+27.97%	672B
NOVO NORDISK A/S	+23.64%	550B
JOHNSON & JOHNSON	-7.02%	351B
MERCK & CO., INC.	+14.85%	317B
ABBVIE INC.	+6.25%	292B
ASTRAZENECA PLC	+2.19%	211B
NOVARTIS AG	-0.40%	203B
ROCHE HOLDING AG	-9.98%	194B
PFIZER, INC.	-11.81%	144B

Other Pharmaceuticals